IRWD
Price
$3.63
Change
-$0.13 (-3.46%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
680.79M
27 days until earnings call
Intraday BUY SELL Signals
ORGO
Price
$1.32
Change
-$0.07 (-5.00%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
177.57M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IRWD vs ORGO

IRWD vs ORGO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IRWD vs. ORGO commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRWD is a Hold and ORGO is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
IRWD vs ORGO: Fundamental Ratings
IRWD
ORGO
OUTLOOK RATING
1..100
8859
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3890
P/E GROWTH RATING
1..100
9753
SEASONALITY SCORE
1..100
9065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRWD's Valuation (39) in the Pharmaceuticals Other industry is in the same range as ORGO (49) in the Financial Conglomerates industry. This means that IRWD’s stock grew similarly to ORGO’s over the last 12 months.

IRWD's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ORGO (100) in the Financial Conglomerates industry. This means that IRWD’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's SMR Rating (98) in the Financial Conglomerates industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's Price Growth Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for ORGO (90) in the Financial Conglomerates industry. This means that IRWD’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's P/E Growth Rating (53) in the Financial Conglomerates industry is somewhat better than the same rating for IRWD (97) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew somewhat faster than IRWD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRWDORGO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
68%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (IRWD: $3.76 vs. ORGO: $1.40)
Brand notoriety: IRWD and ORGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IRWD: 132% vs. ORGO: 90%
Market capitalization -- IRWD: $680.79M vs. ORGO: $177.57M
IRWD [@Pharmaceuticals: Generic] is valued at $680.79M. ORGO’s [@Pharmaceuticals: Generic] market capitalization is $177.57M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRWD’s FA Score shows that 0 FA rating(s) are green while ORGO’s FA Score has 0 green FA rating(s).

  • IRWD’s FA Score: 0 green, 5 red.
  • ORGO’s FA Score: 0 green, 5 red.
According to our system of comparison, IRWD is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRWD’s TA Score shows that 3 TA indicator(s) are bullish while ORGO’s TA Score has 5 bullish TA indicator(s).

  • IRWD’s TA Score: 3 bullish, 5 bearish.
  • ORGO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ORGO is a better buy in the short-term than IRWD.

Price Growth

IRWD (@Pharmaceuticals: Generic) experienced а -10.26% price change this week, while ORGO (@Pharmaceuticals: Generic) price change was -1.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.71%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +29.84%.

Reported Earning Dates

IRWD is expected to report earnings on Oct 29, 2026.

ORGO is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.71% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
IRWD
Daily Signal:
Gain/Loss:
ORGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OOMA20.760.33
+1.62%
Ooma
AVPT14.08N/A
N/A
AvePoint
GPC125.12-0.62
-0.49%
Genuine Parts Company
PARK20.11-0.23
-1.13%
Park Dental Partners Inc.
NCRA1.70-0.10
-5.56%
Nocera

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
-5.29%
ACET - IRWD
30%
Poorly correlated
-7.00%
PRGO - IRWD
29%
Poorly correlated
-5.01%
AMRX - IRWD
27%
Poorly correlated
-0.35%
TLRY - IRWD
26%
Poorly correlated
-4.80%
PAHC - IRWD
24%
Poorly correlated
+0.36%
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIK. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
+2.19%
ANIK - ORGO
36%
Loosely correlated
-1.53%
PRGO - ORGO
31%
Poorly correlated
-5.01%
ACET - ORGO
29%
Poorly correlated
-7.00%
IRWD - ORGO
23%
Poorly correlated
-5.29%
AMPH - ORGO
23%
Poorly correlated
-1.78%
More